November 12, 2018
A key health ministry panel has given the go-ahead for Otsuka Pharmaceutical’s nalmefene, otherwise known as Selincro, for the treatment of alcohol dependency, with its approval now expected by the end of the year. The Pharmaceutical Affairs and Food Sanitation...read more